Zkusit zdarma
Exelixis, Inc.

Exelixis, Inc.

EXEL
Cena:
$ 50.15
+0.50 (1.01%)
Valuace
65
Růst
78
Zdraví
55
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Exelixis: Financial Performance Improves Faster Than Market Expectations

Exelixis: Financial Performance Improves Faster Than Market Expectations

17:26 23-05-2026

Exelixis remains undervalued despite a 13%+ rally post-Q1, supported by robust double-digit growth, ...

Exelixis Eyes CABO Growth as Zanzalintinib Readouts and Potential CRC Launch Near

Exelixis Eyes CABO Growth as Zanzalintinib Readouts and Potential CRC Launch Near

5:04 23-05-2026

Exelixis NASDAQ: EXEL remains focused on expanding its CABO franchise while preparing for potential ...

Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types

Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types

17:00 21-05-2026

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced presentations for it...

Exelixis, Inc. (EXEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript

Exelixis, Inc. (EXEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript

16:00 20-05-2026

Exelixis, Inc. (EXEL) Presents at Stifel 2026 Targeted Oncology Virtual Forum Transcript...

EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study

EXEL Collaborates With MRK for Late-Stage Colorectal Cancer Study

15:35 20-05-2026

Exelixis teams up with Merck to advance zanzalintinib in a phase III colorectal cancer study, expand...

Exelixis, Inc. (EXEL) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Exelixis, Inc. (EXEL) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

11:00 19-05-2026

Exelixis, Inc. (EXEL) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript...

Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer

Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer

8:00 19-05-2026

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that the company has...

Prediction: This Stock Could Double By 2031

Prediction: This Stock Could Double By 2031

19:30 15-05-2026

Exelixis's main product should continue driving growth through the end of the decade. The company is...

Exelixis (EXEL) is a Top-Ranked Momentum Stock: Should You Buy?

Exelixis (EXEL) is a Top-Ranked Momentum Stock: Should You Buy?

10:51 15-05-2026

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t...

Exelixis, Inc. (EXEL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Exelixis, Inc. (EXEL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

15:01 12-05-2026

Exelixis, Inc. (EXEL) Presents at Bank of America Global Healthcare Conference 2026 Transcript...

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May

16:05 07-05-2026

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that company managem...

EXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in Focus

EXEL Q1 Earnings Top Estimates, Colorectal Cancer Drug in Focus

13:01 06-05-2026

EXEL beats Q1 EPS estimates on lower costs and buybacks but misses on revenues; Cabometyx sales lag ...

Here's Why Exelixis (EXEL) is a Strong Value Stock

Here's Why Exelixis (EXEL) is a Strong Value Stock

10:41 06-05-2026

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi...

Exelixis, Inc. (EXEL) Q1 2026 Earnings Call Transcript

Exelixis, Inc. (EXEL) Q1 2026 Earnings Call Transcript

3:31 06-05-2026

Exelixis, Inc. (EXEL) Q1 2026 Earnings Call Transcript...

Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Exelixis (EXEL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

18:30 05-05-2026

Although the revenue and EPS for Exelixis (EXEL) give a sense of how its business performed in the q...

Exelixis (EXEL) Tops Q1 Earnings Estimates

Exelixis (EXEL) Tops Q1 Earnings Estimates

18:16 05-05-2026

Exelixis (EXEL) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Est...

Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update

Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update

16:05 05-05-2026

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for...

Here's Why Exelixis (EXEL) is a Strong Growth Stock

Here's Why Exelixis (EXEL) is a Strong Growth Stock

10:46 04-05-2026

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the ...

Exelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Exelixis (EXEL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

11:08 28-04-2026

Exelixis (EXEL) possesses the right combination of the two key ingredients for a likely earnings bea...

Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Exelixis to Release First Quarter 2026 Financial Results on Tuesday, May 5, 2026

16:05 21-04-2026

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) announced today that its first quart...

close

EXELIXIS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

10-02-2026
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY REPORTED FINANCIAL RESULTS FOR...
Více zde

EXELIXIS ANNOUNCES U.S. FDA ACCEPTED THE NEW DRUG APPLICATION FOR ZANZALINTINIB IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR FOR PATIENTS WITH METASTATIC COLORECTAL CANCER

02-02-2026
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY ANNOUNCED THAT ITS NEW DRUG AP...
Více zde

EXELIXIS TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON TUESDAY, FEBRUARY 10, 2026

27-01-2026
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) ANNOUNCED TODAY THAT ITS FOURTH QUAR...
Více zde

EXELIXIS ANNOUNCES PRELIMINARY FISCAL YEAR 2025 FINANCIAL RESULTS, PROVIDES 2026 FINANCIAL GUIDANCE AND OUTLINES KEY PRIORITIES AND MILESTONES FOR 2026

11-01-2026
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY ANNOUNCED ITS PRELIMINARY UNAU...
Více zde

EXELIXIS AND NATERA TO COLLABORATE ON STELLAR-316, A PHASE 3 PIVOTAL TRIAL OF ZANZALINTINIB FOR PATIENTS WITH COLORECTAL CANCER

07-01-2026
ALAMEDA, CALIF. & AUSTIN, TEXAS--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) AND NATERA (NASDAQ: ...
Více zde

EXELIXIS TO PRESENT AT THE J.P. MORGAN 2026 HEALTHCARE CONFERENCE ON JANUARY 12, 2026

06-01-2026
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY ANNOUNCED THAT MICHAEL M. MORR...
Více zde

EXELIXIS TO WEBCAST VIRTUAL 2025 RESEARCH & DEVELOPMENT (R&D) DAY ON WEDNESDAY, DECEMBER 10, 2025

03-12-2025
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY ANNOUNCED THAT IT WILL WEBCAST...
Více zde

EXELIXIS TO WEBCAST FIRESIDE CHATS AS PART OF UPCOMING INVESTOR CONFERENCES IN NOVEMBER

06-11-2025
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY ANNOUNCED THAT COMPANY MANAGEM...
Více zde

EXELIXIS ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

04-11-2025
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY REPORTED FINANCIAL RESULTS FOR...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

28-10-2025
NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

23-10-2025
NEW YORK , OCT. 23, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

EXELIXIS TO RELEASE THIRD QUARTER 2025 FINANCIAL RESULTS ON TUESDAY, NOVEMBER 4, 2025

21-10-2025
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) ANNOUNCED TODAY THAT ITS THIRD QUART...
Více zde

EXELIXIS ANNOUNCES DETAILED RESULTS FROM PHASE 3 STELLAR-303 PIVOTAL TRIAL EVALUATING ZANZALINTINIB IN COMBINATION WITH AN IMMUNE CHECKPOINT INHIBITOR IN METASTATIC COLORECTAL CANCER PRESENTED AT ESMO 2025 AND PUBLISHED IN THE LANCET

20-10-2025
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY ANNOUNCED DETAILED RESULTS FRO...
Více zde

EXELIXIS ANNOUNCES RESULTS FROM SUBGROUP ANALYSIS OF CABINET PHASE 3 PIVOTAL TRIAL EVALUATING CABOMETYX® (CABOZANTINIB) IN ADVANCED LUNG AND THYMIC NEUROENDOCRINE TUMORS AT ESMO 2025

18-10-2025
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY ANNOUNCED RESULTS FROM A SUBGR...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

13-09-2025
NEW YORK , SEPT. 13, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTO...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

10-09-2025
NEW YORK, SEPT. 10, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVE...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

08-09-2025
NEW YORK , SEPT. 8, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

EXEL INVESTORS HAVE OPPORTUNITY TO JOIN EXELIXIS, INC. FRAUD INVESTIGATION WITH THE SCHALL LAW FIRM

04-09-2025
LOS ANGELES , SEPT. 4, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LITIG...
Více zde

EXEL INVESTORS HAVE OPPORTUNITY TO JOIN EXELIXIS, INC. FRAUD INVESTIGATION WITH THE SCHALL LAW FIRM

02-09-2025
LOS ANGELES--(BUSINESS WIRE)---- $EXEL--EXEL INVESTORS HAVE OPPORTUNITY TO JOIN EXELIXIS, INC. FRAUD...
Více zde

EXELIXIS ANNOUNCES APPOINTMENT OF DANA T. AFTAB, PH.D.

29-08-2025
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY ANNOUNCED IT HAS APPOINTED DAN...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

29-08-2025
NEW YORK, AUG. 29, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

EXELIXIS TO WEBCAST FIRESIDE CHATS AS PART OF UPCOMING INVESTOR CONFERENCES IN SEPTEMBER

27-08-2025
ALAMEDA, CALIF.--(BUSINESS WIRE)--EXELIXIS, INC. (NASDAQ: EXEL) TODAY ANNOUNCED THAT COMPANY MANAGEM...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

25-08-2025
NEW YORK, AUG. 25, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

22-08-2025
NEW YORK , AUG. 22, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

21-08-2025
NEW YORK, AUG. 21, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

17-08-2025
NEW YORK, AUG. 17, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

16-08-2025
NEW YORK , AUG. 16, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

13-08-2025
NEW YORK, AUG. 13, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

11-08-2025
NEW YORK , AUG. 11, 2025 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

INVESTOR ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF EXELIXIS, INC. - EXEL

09-08-2025
NEW YORK, AUG. 09, 2025 (GLOBE NEWSWIRE) -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVES...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-02-10 00:00:008-KStáhnout
2026-02-10 00:00:0010-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-11-07 00:00:008-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-08-29 01:00:008-KStáhnout
2025-08-29 00:00:008-KStáhnout
2025-07-28 01:00:008-KStáhnout
2025-07-28 01:00:0010-QStáhnout
2025-07-28 00:00:008-KStáhnout
2025-07-28 00:00:0010-QStáhnout
2025-06-02 01:00:008-KStáhnout
2025-06-02 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 01:00:0010-QStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-13 00:00:0010-QStáhnout
2025-03-31 01:00:008-KStáhnout
2025-03-31 00:00:008-KStáhnout
2025-02-21 00:00:008-KStáhnout
2025-02-20 23:00:008-KStáhnout
2025-02-11 00:00:008-KStáhnout
2025-02-11 00:00:0010-KStáhnout
2025-02-10 23:00:008-KStáhnout
2025-02-10 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-10-29 00:00:008-KStáhnout
2024-10-29 00:00:0010-QStáhnout
2024-10-28 23:00:008-KStáhnout
2024-10-28 23:00:0010-QStáhnout
2024-10-15 01:00:008-KStáhnout
2024-10-15 00:00:008-KStáhnout
2024-08-06 01:00:008-KStáhnout
2024-08-06 01:00:0010-QStáhnout
2024-08-06 00:00:008-KStáhnout
2024-08-06 00:00:0010-QStáhnout
2024-06-03 01:00:008-KStáhnout
2024-06-03 00:00:008-KStáhnout
2024-05-20 01:00:008-KStáhnout
2024-05-20 00:00:008-KStáhnout
2024-05-10 01:00:008-KStáhnout
2024-05-10 00:00:008-KStáhnout
2024-04-30 01:00:008-KStáhnout
2024-04-30 01:00:0010-QStáhnout
2024-04-30 00:00:008-KStáhnout
2024-04-30 00:00:0010-QStáhnout
2024-03-29 00:00:008-KStáhnout
2024-03-28 23:00:008-KStáhnout
2024-02-06 00:00:008-KStáhnout
2024-02-06 00:00:0010-KStáhnout
2024-02-05 23:00:008-KStáhnout
2024-02-05 23:00:0010-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-20 00:00:008-KStáhnout
2023-12-19 23:00:008-KStáhnout
2023-11-01 00:00:008-KStáhnout
2023-11-01 00:00:0010-QStáhnout
2023-10-31 23:00:008-KStáhnout
2023-10-31 23:00:0010-QStáhnout
2023-09-19 01:00:008-KStáhnout
2023-09-19 00:00:008-KStáhnout
2023-08-23 01:00:008-KStáhnout
2023-08-23 00:00:008-KStáhnout
2023-08-01 01:00:008-KStáhnout
2023-08-01 01:00:0010-QStáhnout
2023-08-01 00:00:008-KStáhnout
2023-08-01 00:00:0010-QStáhnout
2023-07-24 01:00:008-KStáhnout
2023-07-24 00:00:008-KStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-05-09 01:00:008-KStáhnout
2023-05-09 01:00:0010-QStáhnout
2023-05-09 00:00:008-KStáhnout
2023-05-09 00:00:0010-QStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 00:00:008-KStáhnout
2023-04-13 01:00:008-KStáhnout
2023-04-13 00:00:008-KStáhnout
2023-03-22 00:00:008-KStáhnout
2023-03-21 23:00:008-KStáhnout
2023-03-20 00:00:008-KStáhnout
2023-03-19 23:00:008-KStáhnout
2023-02-07 00:00:008-KStáhnout
2023-02-07 00:00:0010-KStáhnout
2023-02-06 23:00:008-KStáhnout
2023-02-06 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-15 00:00:008-KStáhnout
2022-12-14 23:00:008-KStáhnout
2022-11-01 00:00:008-KStáhnout
2022-11-01 00:00:0010-QStáhnout
2022-10-31 23:00:008-KStáhnout
2022-10-31 23:00:0010-QStáhnout
2022-09-02 01:00:008-KStáhnout
2022-09-02 00:00:008-KStáhnout
2022-08-09 01:00:008-KStáhnout
2022-08-09 01:00:0010-QStáhnout
2022-08-09 00:00:008-KStáhnout
2022-08-09 00:00:0010-QStáhnout
2022-07-19 01:00:008-KStáhnout
2022-07-19 00:00:008-KStáhnout
2022-05-27 01:00:008-KStáhnout
2022-05-27 00:00:008-KStáhnout
2022-05-10 01:00:008-KStáhnout
2022-05-10 01:00:0010-QStáhnout
2022-05-10 00:00:008-KStáhnout
2022-05-10 00:00:0010-QStáhnout
2022-04-13 01:00:008-KStáhnout
2022-04-13 00:00:008-KStáhnout
2022-02-23 00:00:008-KStáhnout
2022-02-22 23:00:008-KStáhnout
2022-02-18 00:00:0010-KStáhnout
2022-02-17 23:00:0010-KStáhnout
2022-02-17 00:00:008-KStáhnout
2022-02-16 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2021-12-17 00:00:008-KStáhnout
2021-12-16 23:00:008-KStáhnout
2021-11-02 00:00:008-KStáhnout
2021-11-02 00:00:0010-QStáhnout
2021-11-01 23:00:008-KStáhnout
2021-11-01 23:00:0010-QStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-06-21 01:00:008-KStáhnout
2021-06-21 00:00:008-KStáhnout
2021-05-27 01:00:008-KStáhnout
2021-05-27 00:00:008-KStáhnout
2021-05-11 01:00:008-KStáhnout
2021-05-11 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-03-05 00:00:008-KStáhnout
2021-03-04 23:00:008-KStáhnout
2021-03-03 00:00:008-KStáhnout
2021-03-02 23:00:008-KStáhnout
2021-02-11 00:00:0010-KStáhnout
2021-02-10 23:00:0010-KStáhnout
2021-02-10 00:00:008-KStáhnout
2021-02-09 23:00:008-KStáhnout
2021-02-05 00:00:008-KStáhnout
2021-02-04 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-05-22 01:00:008-KStáhnout
2020-05-22 00:00:008-KStáhnout
2020-05-12 01:00:008-KStáhnout
2020-05-12 00:00:008-KStáhnout
2020-05-05 01:00:008-KStáhnout
2020-05-05 01:00:0010-QStáhnout
2020-05-05 00:00:008-KStáhnout
2020-05-05 00:00:0010-QStáhnout
2020-04-20 01:00:008-KStáhnout
2020-04-20 00:00:008-KStáhnout
2020-03-02 00:00:008-KStáhnout
2020-03-01 23:00:008-KStáhnout
2020-02-25 00:00:008-KStáhnout
2020-02-25 00:00:0010-KStáhnout
2020-02-24 23:00:008-KStáhnout
2020-02-24 23:00:0010-KStáhnout
2020-02-20 00:00:008-KStáhnout
2020-02-19 23:00:008-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2019-12-19 00:00:008-KStáhnout
2019-12-18 23:00:008-KStáhnout
2019-10-30 00:00:008-KStáhnout
2019-10-30 00:00:0010-QStáhnout
2019-10-29 23:00:008-KStáhnout
2019-10-29 23:00:0010-QStáhnout
2019-10-07 01:00:008-KStáhnout
2019-10-07 00:00:008-KStáhnout
2019-09-26 01:00:008-KStáhnout
2019-09-26 00:00:008-KStáhnout
2019-07-31 01:00:008-KStáhnout
2019-07-31 01:00:0010-QStáhnout
2019-07-31 00:00:008-KStáhnout
2019-07-31 00:00:0010-QStáhnout
2019-06-20 01:00:008-KStáhnout
2019-06-20 00:00:008-KStáhnout
2019-05-23 01:00:008-KStáhnout
2019-05-23 00:00:008-KStáhnout
2019-05-01 01:00:008-KStáhnout
2019-05-01 01:00:0010-QStáhnout
2019-05-01 00:00:008-KStáhnout
2019-05-01 00:00:0010-QStáhnout
2019-04-25 01:00:008-KStáhnout
2019-04-25 00:00:008-KStáhnout
2019-04-05 01:00:008-KStáhnout
2019-04-05 00:00:008-KStáhnout
2019-03-05 00:00:008-KStáhnout
2019-03-04 23:00:008-KStáhnout
2019-02-22 00:00:0010-KStáhnout
2019-02-21 23:00:0010-KStáhnout
2019-02-21 00:00:008-KStáhnout
2019-02-20 23:00:008-KStáhnout
2019-02-12 00:00:008-KStáhnout
2019-02-11 23:00:008-KStáhnout
2018-11-01 00:00:008-KStáhnout
2018-11-01 00:00:0010-QStáhnout
2018-10-31 23:00:008-KStáhnout
2018-10-31 23:00:0010-QStáhnout
2018-08-01 01:00:008-KStáhnout
2018-08-01 01:00:0010-QStáhnout
2018-08-01 00:00:008-KStáhnout
2018-08-01 00:00:0010-QStáhnout
2018-05-24 01:00:008-KStáhnout
2018-05-24 00:00:008-KStáhnout
2018-05-02 01:00:008-KStáhnout
2018-05-02 01:00:0010-QStáhnout
2018-05-02 00:00:008-KStáhnout
2018-05-02 00:00:0010-QStáhnout
2018-04-09 01:00:008-KStáhnout
2018-04-09 00:00:008-KStáhnout
2018-02-26 00:00:008-KStáhnout
2018-02-26 00:00:0010-KStáhnout
2018-02-25 23:00:008-KStáhnout
2018-02-25 23:00:0010-KStáhnout
2018-02-16 00:00:008-KStáhnout
2018-02-15 23:00:008-KStáhnout
2017-11-01 00:00:008-KStáhnout
2017-11-01 00:00:0010-QStáhnout
2017-10-31 23:00:008-KStáhnout
2017-10-31 23:00:0010-QStáhnout
2017-09-08 01:00:008-KStáhnout
2017-09-08 00:00:008-KStáhnout
2017-08-02 01:00:008-KStáhnout
2017-08-02 01:00:0010-QStáhnout
2017-08-02 00:00:008-KStáhnout
2017-08-02 00:00:0010-QStáhnout
2017-07-20 01:00:008-KStáhnout
2017-07-20 00:00:008-KStáhnout
2017-05-25 01:00:008-KStáhnout
2017-05-25 00:00:008-KStáhnout
2017-05-11 01:00:008-KStáhnout
2017-05-11 00:00:008-KStáhnout
2017-05-02 01:00:008-KStáhnout
2017-05-02 00:00:008-KStáhnout
2017-05-01 01:00:008-KStáhnout
2017-05-01 01:00:0010-QStáhnout
2017-05-01 00:00:008-KStáhnout
2017-05-01 00:00:0010-QStáhnout
2017-02-27 00:00:008-KStáhnout
2017-02-27 00:00:0010-KStáhnout
2017-02-26 23:00:008-KStáhnout
2017-02-26 23:00:0010-KStáhnout
2017-01-31 00:00:008-KStáhnout
2017-01-30 23:00:008-KStáhnout
2016-12-21 00:00:008-KStáhnout
2016-12-20 23:00:008-KStáhnout
2016-11-22 00:00:008-KStáhnout
2016-11-21 23:00:008-KStáhnout
2016-11-03 00:00:008-KStáhnout
2016-11-03 00:00:0010-QStáhnout
2016-11-02 23:00:008-KStáhnout
2016-11-02 23:00:0010-QStáhnout
2016-09-26 01:00:008-KStáhnout
2016-09-26 00:00:008-KStáhnout
2016-08-22 01:00:008-KStáhnout
2016-08-22 00:00:008-KStáhnout
2016-08-09 01:00:008-KStáhnout
2016-08-09 00:00:008-KStáhnout
2016-08-03 01:00:008-KStáhnout
2016-08-03 01:00:0010-QStáhnout
2016-08-03 00:00:008-KStáhnout
2016-08-03 00:00:0010-QStáhnout
2016-05-26 01:00:008-KStáhnout
2016-05-26 00:00:008-KStáhnout
2016-05-04 01:00:008-KStáhnout
2016-05-04 01:00:0010-QStáhnout
2016-05-04 00:00:008-KStáhnout
2016-05-04 00:00:0010-QStáhnout
2016-02-29 00:00:008-KStáhnout
2016-02-29 00:00:0010-KStáhnout
2016-02-28 23:00:008-KStáhnout
2016-02-28 23:00:0010-KStáhnout
2016-02-16 00:00:008-KStáhnout
2016-02-15 23:00:008-KStáhnout
2015-11-10 00:00:008-KStáhnout
2015-11-10 00:00:0010-QStáhnout
2015-11-09 23:00:008-KStáhnout
2015-11-09 23:00:0010-QStáhnout
2015-08-11 01:00:008-KStáhnout
2015-08-11 01:00:0010-QStáhnout
2015-08-11 00:00:008-KStáhnout
2015-08-11 00:00:0010-QStáhnout
2015-07-24 01:00:008-KStáhnout
2015-07-24 00:00:008-KStáhnout
2015-07-20 01:00:008-KStáhnout
2015-07-20 00:00:008-KStáhnout
2015-07-16 01:00:008-KStáhnout
2015-07-16 00:00:008-KStáhnout
2015-07-01 01:00:008-KStáhnout
2015-07-01 00:00:008-KStáhnout
2015-05-28 01:00:008-KStáhnout
2015-05-28 00:00:008-KStáhnout
2015-04-30 01:00:008-KStáhnout
2015-04-30 00:00:0010-QStáhnout
2015-03-09 00:00:008-KStáhnout
2015-03-08 23:00:008-KStáhnout
2015-03-02 00:00:0010-KStáhnout
2015-03-01 23:00:0010-KStáhnout
2015-02-24 00:00:008-KStáhnout
2015-02-23 23:00:008-KStáhnout
2015-02-11 00:00:008-KStáhnout
2015-02-10 23:00:008-KStáhnout
2014-12-04 23:00:008-KStáhnout
2014-11-03 23:00:008-KStáhnout
2014-10-16 00:00:008-KStáhnout
2014-10-15 00:00:008-KStáhnout
2014-09-25 00:00:008-KStáhnout
2014-09-05 00:00:008-KStáhnout
2014-07-31 00:00:0010-QStáhnout
2014-07-17 00:00:008-KStáhnout
preloader